UnknownNot Applicable

Short Post-operative Antibacterial Therapy in Complicated Appendicitis: Oral Versus Intravenous

Estonia100 participantsStarted 2020-11-01

Plain-language summary

Short Post-operative Antibacterial Therapy in Complicated Appendicitis: Oral Versus Intravenous is a prospective randomized controlled trial comparing 24 hour intravenous antibacterial therapy to 24 hour oral antibacterial therapy after surgery in complicated appendicitis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients diagnosed with acute appendicitis and are candidates for laparoscopic appendectomy. Exclusion Criteria: Patients with compromised immune system (HIV, diabetes), ongoing or completed radio-chemotherapy in past 5 years, prosthetic heart valve, vascular prosthesis, pregnancy.

What they're measuring

Infectious complications

Timeframe: 30 days

Trial details

NCT IDNCT04947748

SponsorNorth Estonia Medical Centre

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-12-31

Contact for this trial

Edgar Lipping, MD

6171520 edgar.lipping@regionaalhaigla.ee

View on ClinicalTrials.gov More Acute Appendicitis trials